ArticleNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition2026
Comparative analysis of the relationship of sarcopenia or sarcopenic obesity with functional impairment: A cross-sectional study.
Article in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative analysis of the relationship of sarcopenia or sarcopenic obesity with functional impairment: A cross-sectional study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Growing evidence suggests that sarcopenic obesity (SO) may have a more pronounced effect on functionality compared with isolated sarcopenia, but research in this crucial area remains scarce. Therefore, this study aimed to evaluate whether the combination of sarcopenia and obesity is associated with increased functional impairment in hospitalized older adults. This is a cross-sectional study involving hospitalized older patients. SO was defined as the simultaneous presence of obesity and sarcopenia. Obesity was determined based on a high body fat percentage obtained through bioelectrical impedance analysis, whereas both reduced muscle strength and mass identified sarcopenia. Functionality was evaluated using the Barthel Index and the gait speed test. Additional sociodemographic, clinical, nutrition, and behavioral data were assessed. A total of 176 patients were included in our study. The mean age was 69.8 ± 7.8 years. The frequency of sarcopenia was 37.5%, whereas SO was found in 17.6%. Barthel Index indicated that 64.2% of patients exhibited functional dependency, whereas 87.5% had a slow gait speed. Logistic regression analysis revealed that SO was independently associated with poor functionality by the Barthel Index (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1-8.5) and slow gait speed (OR, 3.3; 95% CI, 1.1-9.8). Patients with SO showed poorer functional capacity compared with those with obesity alone (P < 0.05), but not compared with those with sarcopenia alone (P > 0.05). In conclusion, we observe that SO was associated with diminished functionality but did not elevate the risk compared with sarcopenia alone.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.